Why must Questran (cholestyramine) be administered an hour before other medications in adults with a history of cardiovascular disease or high cholesterol?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 26, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Why Questran Must Be Spaced from Other Medications

Questran (cholestyramine) is a bile acid sequestrant that physically binds to other medications in the gastrointestinal tract, preventing their absorption—therefore, other medications must be taken at least 1 hour before or 4-6 hours after Questran to avoid impeding their absorption. 1, 2

Mechanism of Drug Interaction

  • Cholestyramine is a positively-charged resin that works by binding bile acids in the intestine, but this binding mechanism is non-selective 2
  • The resin can bind to and sequester other orally administered medications, physically trapping them and preventing their absorption from the gastrointestinal tract 1
  • This interaction is unavoidable for drugs that undergo enterohepatic circulation, as cholestyramine will continue to bind these medications even when properly spaced 2

FDA-Mandated Timing Recommendations

The FDA drug label explicitly states: "SINCE CHOLESTYRAMINE RESIN MAY BIND OTHER DRUGS GIVEN CONCURRENTLY, IT IS RECOMMENDED THAT PATIENTS TAKE OTHER DRUGS AT LEAST 1 HOUR BEFORE OR 4 TO 6 HOURS AFTER CHOLESTYRAMINE RESIN (OR AT AS GREAT AN INTERVAL AS POSSIBLE) TO AVOID IMPEDING THEIR ABSORPTION." 2

  • The American College of Cardiology guidelines reinforce this timing: other medications should be given at least 4 hours before bile acid sequestrants 1
  • When ezetimibe is used with cholestyramine, it must be taken either 2 hours before or 4 hours after the bile acid sequestrant 1

High-Risk Medication Interactions

Certain medications require particularly careful attention to timing with cholestyramine 1, 2:

  • Warfarin: Cholestyramine interferes with warfarin absorption and its enterohepatic circulation; spacing by 2 hours before or 6 hours after only partially mitigates this interaction 1, 2
  • Thyroid replacement therapy: Absorption is significantly reduced without proper spacing 1
  • Oral contraceptives (ethinyl estradiol and norethindrone): Must be given 4 hours before cholestyramine 1
  • Cyclosporine: Known to have decreased absorption, though one study showed 4g cholestyramine at noon did not interfere with morning cyclosporine dosing 1, 3
  • Cardiovascular medications: Olmesartan, phenytoin, sulfonylureas all require the 4-hour spacing 1
  • Digitalis: Particularly dangerous as the drug may have been titrated to maintenance levels while on cholestyramine; discontinuing cholestyramine could result in toxic digitalis levels 2

Fat-Soluble Vitamin Considerations

  • Cholestyramine interferes with normal fat digestion and absorption, preventing absorption of fat-soluble vitamins A, D, E, and K 1, 2
  • For long-term cholestyramine therapy, concomitant supplementation with water-miscible or parenteral forms of fat-soluble vitamins should be considered 2
  • Oral vitamins should be given at least 4 hours before cholestyramine 1

Clinical Pitfalls to Avoid

  • Do not assume proper spacing eliminates all interactions: For drugs undergoing enterohepatic circulation, some interaction is unavoidable 2
  • Monitor INR frequently when initiating cholestyramine in patients on warfarin, then periodically thereafter 1
  • For patients on digitalis: Discontinuing cholestyramine poses a hazard if digitalis has been titrated to maintenance levels while the patient was taking cholestyramine 2
  • Pregnant patients: Regular prenatal vitamin supplementation may be inadequate due to interference with fat-soluble vitamin absorption 2

Practical Dosing Strategy

The most practical approach is to administer all other medications either 1 hour before breakfast or 4-6 hours after the cholestyramine dose, with cholestyramine typically given with meals 1, 2. This maximizes the interval between cholestyramine and other medications while maintaining adherence.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Does cholestyramine interfere with cyclosporine absorption? A prospective study in renal transplant patients.

ASAIO journal (American Society for Artificial Internal Organs : 1992), 1995

Related Questions

How to manage a 57-year-old female with hypercholesterolemia, hyperlipidemia, mildly elevated liver enzymes, impaired glucose regulation, and Alternaria species infection?
What is the best management approach for a 54-year-old male with significantly elevated Gamma-Glutamyl Transferase (GGT) and hyperlipidemia, characterized by high total cholesterol and Low-Density Lipoprotein (LDL) levels?
What are the alternatives to cholestyramine (bile acid sequestrant) for treating high cholesterol?
What is the appropriate treatment plan for a patient with elevated liver enzymes and lipid profile, indicating potential liver dysfunction and increased risk of cardiovascular disease?
What is the appropriate treatment for a 39-year-old male with hyperlipidemia (elevated LDL) and no diabetes?
What is the recommended dose of amoxicillin for a 58-pound patient with otitis media?
What is the best course of action for a patient with a history of similar episodes, negative imaging results, and recent severe stress, who has experienced a potential trigger of caffeine withdrawal?
What is Neuroleptic Malignant Syndrome (NMS), its causes, symptoms, and treatment options, particularly in younger adults with a history of psychiatric disorders or neurological conditions?
What is the difference between Neuroleptic Malignant Syndrome (NMS) and serotonin syndrome?
Why does tinnitus increase in an adult with a history of recurrent headache episodes triggered by stress and caffeine withdrawal?
What is the appropriate management for a patient presenting with lead pipe rigidity, a symptom of Neuroleptic Malignant Syndrome (NMS), who is currently on antipsychotic medications?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.